Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Potential of cerebrocrast in diabetes suggested by animal data

July 12, 1999

Patient enrollment completed in study of shortened Targis treatment for BPH

July 12, 1999

Selective beta3-receptor agonists in early development at Lilly

July 9, 1999

Phase I trial of ThGRF1-44 successfully completed

July 9, 1999

Sleep improvements associated with HRT in postmenopausal women

July 7, 1999

Symposium explores potential of bimoclomol in diabetic complications and other disorders

July 7, 1999

Sanofi-Synthelabo's SR-58611 normalizes wound healing in diabetic and obese mice

July 6, 1999

Anorexigenic cytokine gene therapy: a new approach to treating obesity

July 6, 1999

Phenylcarboxylates for lipid disorders synthesized and tested at Taiho

July 6, 1999

Unimed seeks approval for Androgel in the U.S.

July 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...